Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia
· Delayed Price · Currency is MYR 1.500
+0.020 (1.35%)
At close: Mar 6, 2026
Duopharma Biotech Berhad Revenue
In the year 2025, Duopharma Biotech Berhad had annual revenue of 931.69M MYR with 14.50% growth. Duopharma Biotech Berhad had revenue of 224.69M in the quarter ending December 31, 2025, with 16.01% growth.
Revenue
931.69M
Revenue Growth
+14.50%
P/S Ratio
1.44
Revenue / Employee
476.08K
Employees
1,957
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 931.69M | 118.00M | 14.50% |
| Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
| Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
| Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
| Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.91B |
| Kotra Industries Berhad | 230.26M |
| Y.S.P. Southeast Asia Holding Berhad | 365.12M |
| Sunzen Group Berhad | 80.19M |
| Rhone Ma Holdings Berhad | 223.68M |
| Nova Wellness Group Berhad | 46.12M |
| PeterLabs Holdings Berhad | 135.45M |
| Bioalpha Holdings Berhad | 11.48M |